HIVE vs IREN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Mar 31, 2026

HIVE

50.0
AI Score
VS
HIVE Wins

IREN

49.9
AI Score

Investment Advisor Scores

HIVE

50score
Recommendation
HOLD

IREN

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HIVE IREN Winner
Forward P/E 33.8983 62.5 HIVE
PEG Ratio 0 4.0547 Tie
Revenue Growth 218.6% 59.0% HIVE
Earnings Growth -99.9% 42.9% IREN
Tradestie Score 50.0/100 49.9/100 HIVE
Profit Margin -48.6% 51.5% IREN
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.